Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexJagath R. Junutula, William Mallet, Helga Raab et al.|Nature Biotechnology|2008Cited by 1.4k
Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> ActivityThomas H. Pillow, Peter S. Dragovich, Geoffrey Del Rosario et al.|ChemMedChem|2019Cited by 193